apnews.com
Open in
urlscan Pro
34.111.72.3
Public Scan
URL:
https://apnews.com/article/wegovy-ozempic-zepbound-medicare-obesity-weight-loss-02d4500e737d30d070d70907521a4fe0
Submission: On January 01 via manual from US — Scanned from US
Submission: On January 01 via manual from US — Scanned from US
Form analysis 5 forms found in the DOM
https://apnews.com/search#nt=navsearch
<form class="SearchOverlay-search-form" action="https://apnews.com/search#nt=navsearch" novalidate="" autocomplete="off">
<label class="SearchOverlay-search-label">
<input placeholder="Keyword Search..." type="text" class="SearchOverlay-search-input" name="q" required="true">
<span class="sr-only"> Search Query </span>
<button type="submit" class="SearchOverlay-search-submit">
<svg>
<use xlink:href="#icon-magnify"></use>
</svg>
<span class="sr-only">Submit Search</span>
</button>
</label>
</form>https://apnews.com/search#nt=navsearch
<form class="SearchOverlay-search-form" action="https://apnews.com/search#nt=navsearch" novalidate="" autocomplete="off">
<label class="SearchOverlay-search-label">
<input placeholder="Keyword Search..." type="text" class="SearchOverlay-search-input" name="q" required="true">
<span class="sr-only"> Search Query </span>
<button type="submit" class="SearchOverlay-search-submit">
<svg>
<use xlink:href="#icon-magnify"></use>
</svg>
<span class="sr-only">Submit Search</span>
</button>
</label>
</form><form id="adl-user-report-form" novalidate="">
<div style="padding:0; margin: 0 0 0;">
<div style="width:100%;display:none;height: 35px;line-height:35px;font-size:13px;padding:0 12px;color:white;background-color:#FF3860;border-radius:2px;margin-bottom:10px; " id="adl-category-error">Please make a selection.</div>
<label style="display: block;line-height: 0; font-size: 16px; margin: 15px 0 15px;">
<input style="margin:0 8px 0 0;vertical-align: middle;transform: translateY(-0.15em);-webkit-appearance: radio;box-sizing: border-box;" type="radio" name="category" value="Plays Sound" required=""> Plays sound </label>
<label style="display: block;line-height: 0; font-size: 16px; margin: 15px 0 15px;">
<input style="margin:0 8px 0 0;vertical-align: middle;transform: translateY(-0.15em);-webkit-appearance: radio;box-sizing: border-box;" type="radio" name="category" value="Adult Content" required=""> Contains adult content </label>
<label style="display: block;line-height: 0; font-size: 16px; margin: 15px 0 15px;">
<input style="margin:0 8px 0 0;vertical-align: middle;transform: translateY(-0.15em);-webkit-appearance: radio;box-sizing: border-box;" type="radio" name="category" value="Covers the Page" required=""> Covers the page </label>
<label style="display: block;line-height: 0; font-size: 16px; margin: 15px 0 15px;">
<input style="margin:0 8px 0 0;vertical-align: middle;transform: translateY(-0.15em);-webkit-appearance: radio;box-sizing: border-box;" type="radio" name="category" value="Other" required=""> Other </label>
<h2 style="font-size:20px;font-weight:bold;color:rgb(58,58,58);text-align:left;margin:25px 0 15px;">Additional Information</h2>
<div style="width:100%;display:none;height: 35px;line-height:35px;font-size:13px;padding:0 12px;color:white;background-color:#FF3860;border-radius:2px;margin-bottom:10px; " id="adl-text-minlen-error">Please help us by describing the ad.</div>
<div style="width:100%;display:none;height: 35px;line-height:35px;font-size:13px;padding:0 12px;color:white;background-color:#FF3860;border-radius:2px;margin-bottom:10px; " id="adl-text-maxlen-error">Only 500 characters are allowed.</div>
<textarea id="adl-user-feedback" style="box-sizing:border-box;resize: none; margin:0;width:100%;font-size:14px;line-height:18px;height:100px;border:1px solid #B0B0B0;padding:11px 15px;border-radius:2px;" minlength="3" maxlength="500"
placeholder="What does the ad say, who is the advertiser, what does the ad look like?" name="user_feedback"></textarea>
</div>
<button type="button"
style="margin-left:auto;margin-right:auto;margin: 20px auto 0;width:200px;cursor:pointer;background-color:#7c6bf7;display:block;color:#fff;border-radius:2px;border:none;padding:15px 40px;font-weight:700;text-align:center;box-sizing:border-box;font-size:16px;"
id="adl-report-ad-modal__submit-button">Report ad</button>
</form>POST https://api.bounceexchange.com/capture/submit
<form id="bx-form-2407156-step-1" bx-novalidate="true" method="post" action="https://api.bounceexchange.com/capture/submit" onsubmit="return bouncex.submitCampaignStep(2407156); return false" onreset="bouncex.close_ad(2407156); return false"
aria-labelledby="bx-campaign-ally-title-2407156" class="bx-ally-no-focus"><input type="hidden" name="campaign_id" value="2407156">
<div class="bx-group bx-group-default bx-group-2407156-KMel3F5 bx-group-KMel3F5" id="bx-group-2407156-KMel3F5"><input type="hidden" name="bx_submitted_newsletter_id" value="morning_wire" class="bx-el bx-input bx-input-hidden">
<div class="bx-row bx-row-image bx-row-image-default bx-row-yLNESxe bx-element-2407156-yLNESxe" id="bx-element-2407156-yLNESxe"><img src="//assets.bounceexchange.com/assets/uploads/clients/3836/creatives/291d01de0c1f96f9054523644d779554.png"
alt="AP" width="1297" height="1501"></div>
</div>
<div class="bx-group bx-group-primary bx-group-2407156-9sIfbYI bx-group-9sIfbYI" id="bx-group-2407156-9sIfbYI">
<div class="bx-2-heading wknd-ally-focus" id="bx-group-2407156-9sIfbYI-h2" tabindex="-1" role="heading" aria-level="2">
<div class="bx-row bx-row-text bx-row-text-subheadline bx-row-papMfzx bx-element-2407156-papMfzx" id="bx-element-2407156-papMfzx">
<div>Never miss what matters</div>
</div>
<div class="bx-row bx-row-text bx-row-text-headline bx-row-Gf99nBf bx-element-2407156-Gf99nBf" id="bx-element-2407156-Gf99nBf">
<div>Start your day with <br><span style="font-weight: bold;">The Morning Wire </span></div>
</div>
<div class="bx-row bx-row-text bx-row-text-default bx-row-wtKvYMP bx-element-2407156-wtKvYMP" id="bx-element-2407156-wtKvYMP">
<div>Get the facts you need — now with a new look.</div>
</div>
</div>
</div>
<div class="bx-group bx-group-default bx-group-2407156-CTNAf7Z bx-group-CTNAf7Z" id="bx-group-2407156-CTNAf7Z">
<div class="bx-row bx-row-input bx-row-input-default bx-row-tTD3sSD bx-element-2407156-tTD3sSD" id="bx-element-2407156-tTD3sSD">
<div class="bx-inputwrap"><input class="bx-el bx-input" id="bx-element-2407156-tTD3sSD-input" type="email" name="email" placeholder="Email address" aria-required="true"></div>
<div class="bx-component bx-component-validation bx-vtext bx-error-2407156-email" id="bx-error-2407156-email">Please enter above</div>
</div>
<div class="bx-row bx-row-checkbox bx-row-checkbox-default bx-row-YRynYX5 bx-element-2407156-YRynYX5" id="bx-element-2407156-YRynYX5"><label class="bx-label"><input class="bx-checkelem bx-input" id="bx-element-2407156-YRynYX5-input"
type="checkbox" name="consent" value="1" aria-required="true"><span class="bx-component bx-checkshape"><svg class="bx-check-svg" viewBox="0 0 22 22">
<polyline class="bx-svg-vector" points="17.9,6.2 8.3,15.8 4.1,11.6 "></polyline>
</svg></span><span class="bx-labeltext"><span class="bx-ally-label"></span>By checking this box, you agree to AP's <a href="https://apnews.com/termsofservice" target="_blank" style="text-decoration: underline;">Terms of Use</a> and
acknowledge that AP may collect and use your data pursuant to our <a href="https://apnews.com/privacystatement" target="_blank" style="text-decoration: underline;">Privacy Policy.</a></span></label>
<div class="bx-component bx-component-validation bx-vtext bx-error-2407156-consent" id="bx-error-2407156-consent">Please enter above</div>
</div>
<div class="bx-row bx-row-submit bx-row-submit-default bx-row-QtAlH4B bx-element-2407156-QtAlH4B" id="bx-element-2407156-QtAlH4B"><button type="submit" class="bx-button" data-click="submit" data-step-delay="0" data-submit-jump="0"
data-submit-force="1">Join now</button></div>
<div class="bx-row bx-row-submit bx-row-submit-no bx-row-3lqb4uR bx-element-2407156-3lqb4uR" id="bx-element-2407156-3lqb4uR"><button type="reset" class="bx-button" data-click="close" aria-label="Decline; close the dialog">Decline</button></div>
</div>
<div class="bx-group bx-group-default bx-group-2407156-in33W8E bx-group-in33W8E" id="bx-group-2407156-in33W8E">
<div class="bx-row bx-row-text bx-row-text-default bx-row-FmMO7sg bx-element-2407156-FmMO7sg" id="bx-element-2407156-FmMO7sg">
<div></div>
</div>
</div><input autocomplete="carb-trap" type="input" name="carb-trap" tabindex="-1" aria-hidden="true" class="bx-input bx-carb-trap">
</form>POST https://api.bounceexchange.com/capture/submit
<form id="bx-form-2407156-step-2" bx-novalidate="true" method="post" action="https://api.bounceexchange.com/capture/submit" onsubmit="return bouncex.submitCampaignStep(2407156); return false" onreset="bouncex.close_ad(2407156); return false"
aria-labelledby="bx-campaign-ally-title-2407156" class="bx-ally-no-focus"><input type="hidden" name="campaign_id" value="2407156">
<div class="bx-group bx-group-default bx-group-2407156-W1nHhWM bx-group-W1nHhWM" id="bx-group-2407156-W1nHhWM"><input type="hidden" name="bx_multi_newsletter" value="1" class="bx-el bx-input bx-input-hidden"><input type="hidden"
name="post_submit_list" value="" class="bx-el bx-input bx-input-hidden">
<div class="bx-row bx-row-image bx-row-image-default bx-row-ZLtpDyI bx-element-2407156-ZLtpDyI" id="bx-element-2407156-ZLtpDyI"><img src="//assets.bounceexchange.com/assets/uploads/clients/3836/creatives/291d01de0c1f96f9054523644d779554.png"
alt="AP" width="1297" height="1501"></div>
</div>
<div class="bx-group bx-group-primary bx-group-2407156-qXAeX0R bx-group-qXAeX0R" id="bx-group-2407156-qXAeX0R">
<div class="bx-2-heading wknd-ally-focus" id="bx-group-2407156-qXAeX0R-h2" tabindex="-1" role="heading" aria-level="2">
<div class="bx-row bx-row-text bx-row-text-headline bx-row-UidENVU bx-element-2407156-UidENVU" id="bx-element-2407156-UidENVU">
<div>You're subscribed!</div>
</div>
<div class="bx-row bx-row-text bx-row-text-default bx-row-iYx4PW6 bx-element-2407156-iYx4PW6" id="bx-element-2407156-iYx4PW6">
<div>Interested in more?</div>
</div>
</div>
</div>
<div class="bx-group bx-group-default bx-group-2407156-mVICVq1 bx-group-mVICVq1" id="bx-group-2407156-mVICVq1">
<div class="bx-row bx-row-checkbox bx-row-checkbox-default bx-row-cBTCXze bx-element-2407156-cBTCXze" id="bx-element-2407156-cBTCXze"><label class="bx-label"><input class="bx-checkelem bx-input" id="bx-element-2407156-cBTCXze-input"
type="checkbox" name="PhotoGallery" value="1" aria-required="false"><span class="bx-component bx-checkshape"><svg class="bx-check-svg" viewBox="0 0 22 22">
<polyline class="bx-svg-vector" points="17.9,6.2 8.3,15.8 4.1,11.6 "></polyline>
</svg></span><span class="bx-labeltext"><span class="bx-ally-label"></span>Photo Gallery, See the news through AP’s lens. Our most compelling photos - delivered Sundays.</span></label>
<div class="bx-component bx-component-validation bx-vtext bx-error-2407156-PhotoGallery" id="bx-error-2407156-PhotoGallery">Please enter above</div>
</div>
</div>
<div class="bx-group bx-group-default bx-group-2407156-iElvSmL bx-group-iElvSmL" id="bx-group-2407156-iElvSmL">
<div class="bx-row bx-row-submit bx-row-submit-default bx-row-u73tskj bx-element-2407156-u73tskj" id="bx-element-2407156-u73tskj"><button type="submit" class="bx-button" data-click="submit" data-step-delay="0" data-submit-jump="0"
data-submit-force="1">Join now</button></div>
<div class="bx-row bx-row-submit bx-row-submit-no bx-row-zZOCNjX bx-element-2407156-zZOCNjX" id="bx-element-2407156-zZOCNjX"><button type="reset" class="bx-button" data-click="close" aria-label="No thanks; close the dialog">No thanks</button>
</div>
</div><input autocomplete="carb-trap" type="input" name="carb-trap" tabindex="-1" aria-hidden="true" class="bx-input bx-carb-trap">
</form>Text Content
Enable accessibility
Advertisement
EVEN WHEN THE NEWS IS FREE, JOURNALISM IS NOT.
SUPPORT INDEPENDENT, FACT-BASED JOURNALISM.
DONATE
Menu
Menu
* World
* U.S.
* Politics
* Sports
* Entertainment
* Business
* Science
* Fact Check
* Oddities
* Health
* Video
* Climate
* Spotlight
* Photography
* Tech
* Lifestyle
* Religion
* Press Releases
* ...
* World
* Israel-Hamas War
* Russia-Ukraine War
* Latin America
* Europe
* Africa
* Middle East
* Asia Pacific
* U.S. News
* Australia
* China
* U.S.
* Politics
* Joe Biden
* Election 2024
* Congress
* Sports
* AP Top 25 College Football Poll
* NFL
* MLB
* NHL
* NBA
* WNBA
* Soccer
* Tennis
* Golf
* Entertainment
* Movie reviews
* Book reviews
* Celebrity
* Television
* Music
* Business
* Inflation
* Financial Markets
* Business Highlights
* Financial wellness
* Science
* Fact Check
* Oddities
* Health
* Video
* Climate
* Spotlight
* Photography
* Tech
* Artificial Intelligence
* Social Media
* Lifestyle
* Religion
* Press Releases
Search Query Submit Search
Show Search
* World
* Israel-Hamas War
* Russia-Ukraine War
* Latin America
* Europe
* Africa
* Middle East
* Asia Pacific
* U.S. News
* Australia
* China
* U.S.
* Politics
* Joe Biden
* Election 2024
* Congress
* Sports
* AP Top 25 College Football Poll
* NFL
* MLB
* NHL
* NBA
* WNBA
* Soccer
* Tennis
* Golf
* Entertainment
* Movie reviews
* Book reviews
* Celebrity
* Television
* Music
* Business
* Inflation
* Financial Markets
* Business Highlights
* Financial wellness
* Science
* Fact Check
* Oddities
* Health
* Video
* Climate
* Spotlight
* Photography
* Tech
* Artificial Intelligence
* Social Media
* Lifestyle
* Religion
* Press Releases
*
* The Associated Press is an independent global news organization dedicated to
factual reporting. Founded in 1846, AP today remains the most trusted source
of fast, accurate, unbiased news in all formats and the essential provider of
the technology and services vital to the news business. More than half the
world’s population sees AP journalism every day.
*
* *
twitter
*
instagram
*
facebook
*
* The Associated Press
* ap.org
* Careers
* Advertise with us
* Contact Us
* Accessibility Statement
* Manage Your Choices
* Terms of Use
* Privacy Policy
*
* More From AP News
* About
* AP News Values and Principles
* AP’s Role in Elections
* AP Leads
* AP Definitive Source Blog
* AP Images Spotlight Blog
* AP Stylebook
*
* Copyright 2023 The Associated Press. All Rights Reserved.
Israel-Hamas war
New Year 2024
Miami Dolphins
Store hours today
NFL
Health
NEW WEIGHT LOSS DRUGS ARE OUT OF REACH FOR MILLIONS OF OLDER AMERICANS BECAUSE
MEDICARE WON’T PAY
1 of 2 |
FILE - A waist is measured during an obesity prevention study in Chicago, Jan.
20, 2010. (AP Photo/M. Spencer Green, File)
Read More
2 of 2 |
FILE - The U.S. Medicare Handbook is photographed in Washington, Nov. 8, 2018.
Obesity drugs like Wegovy and Zepbound that are capturing the attention of
celebrities and showing promising results in helping people shed pounds will
stay out of reach for America’s older adults. A decades-old law on the books
bans Medicare from paying for weight loss drugs. (AP Photo/Pablo Martinez
Monsivais, File)
Read More
New weight loss drugs are out of reach for millions of older Americans because
Medicare won’t pay
1 of 2 |
FILE - A waist is measured during an obesity prevention study in Chicago, Jan.
20, 2010. (AP Photo/M. Spencer Green, File)
Read More
1 of 2
FILE - A waist is measured during an obesity prevention study in Chicago, Jan.
20, 2010. (AP Photo/M. Spencer Green, File)
Share
Share
*
Copy
Link copied
*
Email
*
Facebook
*
X
*
Reddit
*
LinkedIn
*
Pinterest
*
Flipboard
*
Print
Read More
2 of 2 |
FILE - The U.S. Medicare Handbook is photographed in Washington, Nov. 8, 2018.
Obesity drugs like Wegovy and Zepbound that are capturing the attention of
celebrities and showing promising results in helping people shed pounds will
stay out of reach for America’s older adults. A decades-old law on the books
bans Medicare from paying for weight loss drugs. (AP Photo/Pablo Martinez
Monsivais, File)
Read More
2 of 2
FILE - The U.S. Medicare Handbook is photographed in Washington, Nov. 8, 2018.
Obesity drugs like Wegovy and Zepbound that are capturing the attention of
celebrities and showing promising results in helping people shed pounds will
stay out of reach for America’s older adults. A decades-old law on the books
bans Medicare from paying for weight loss drugs. (AP Photo/Pablo Martinez
Monsivais, File)
Share
Share
*
Copy
Link copied
*
Email
*
Facebook
*
X
*
Reddit
*
LinkedIn
*
Pinterest
*
Flipboard
*
Print
Read More
By AMANDA SEITZ
Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Updated
12:23 PM HST, December 28, 2023
Share
Share
*
Copy
Link copied
*
Email
*
Facebook
*
X
*
Reddit
*
LinkedIn
*
Pinterest
*
Flipboard
*
Print
WASHINGTON (AP) — New obesity drugs are showing promising results in helping
some people shed pounds but the injections will remain out of reach for millions
of older Americans because Medicare is forbidden to cover such medications.
Drugmakers and a wide-ranging and growing bipartisan coalition of lawmakers are
gearing up to push for that to change next year.
As obesity rates rise among older adults, some lawmakers say the United States
cannot afford to keep a decades-old law that prohibits Medicare from paying for
new weight loss drugs, including Wegovy and Zepbound. But research shows the
initial price tag of covering those drugs is so steep it could drain Medicare’s
already shaky bank account.
A look at the debate around if — and how — Medicare should cover obesity drugs:
Related Coverage
FDA says fake Ozempic shots are being sold through some legitimate sources
A new study bolsters evidence that severe obesity is increasing in young kids in
the US
Pfizer nixes more study of twice-daily obesity pill treatment that made many
patients nauseous
WHAT OBESITY DRUGS ARE ON THE MARKET AND HOW DO THEY WORK?
The Food and Drug Administration has in recent years approved a new class of
weekly injectables, Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, to treat
obesity.
People can lose as much as 15% to 25% of their body weight on the drugs, which
imitate the hormones that regulate appetites by communicating fullness between
the gut and brain when people eat.
The cost of the drugs, beloved by celebrities, has largely limited them to the
wealthy. A monthly supply of Wegovy rings up at $1,300 and Zepbound will put you
out $1,000. Shortages for the drugs have also limited the supplies. Private
insurers often do not cover the medications or place strict restrictions on who
can access them.
Last month, a large, international study found a 20% reduced risk of serious
heart problems such as heart attacks in patients who took Wegovy.
WHY DOESN’T MEDICARE COVER THE DRUGS?
Long before Oprah Winfrey and TikTok influencers alike gushed about the benefits
of these weight loss drugs, Congress made a rule: Medicare Part D, the health
insurance plan for older Americans to get prescriptions, could not cover
medications used to help gain or lose weight. Medicare will cover obesity
screening and behavioral treatment if a person has a body mass index over 30.
People with BMIs over 30 are considered obese.
The rule was tacked onto legislation passed by Congress in 2003 that overhauled
Medicare’s prescription drug benefits.
Lawmakers balked at paying high costs for drugs to treat a condition that was
historically regarded as cosmetic. Safety problems in the 1990s with the
anti-obesity treatment known as fen-phen, which had to be withdrawn from the
market, were also fresh in their minds.
Medicaid, the state and federal partnership program for low-income people, does
cover the drugs in some areas, but access is fragmented.
THE CONVERSATION IS SHIFTING
New studies are showing the drugs do more than help patients slim down.
Rep. Brad Wenstrup, R-Ohio, introduced legislation with Rep. Raul Ruiz,
D-Calif., this year that would allow Medicare to cover the now-forbidden
anti-obesity drugs, therapy, nutritionists and dietitians.
“For years there was a stigma against these people, then there was a stigma
about talking about obesity,” Wenstrup said in an interview with The Associated
Press. “Now we’re in a place where we’re saying this is a health problem we need
to deal with this.”
He believes the intervention could alleviate all sorts of ailments associated
with obesity that cost the system money.
“The problem is so prevalent,” Wenstrup said. “People are starting to realize
you have to take into consideration the savings that comes with better health.”
Last year, about 40% of the nearly 66 million people enrolled in Medicare had
obesity. That roughly mirrors the larger U.S. population, where 42% of adults
struggle with obesity, according to the Centers for Disease Control and
Prevention.
Notably, Medicare does cover certain surgical procedures to treat medical
complications of obesity in people with a BMI of 35 and at least one related
condition. Congress approved the exception in 2006, noted Mark McClellan, a
former head of the Centers for Medicare and Medicaid Services and the FDA.
The 17-year-old law may provide a blueprint for expanding coverage of the new
drugs, which mirror the results of bariatric surgery in some cases, McClellan
said. Evidence showed that the surgery reduced the risks of death and serious
illness from conditions related to obesity.
“And that’s been the basis for coverage all this time,” McClellan said.
COST IS NOW THE ISSUE
Still, the upfront price tag for lifting the rule remains a challenge.
Some research shows offering weight loss drugs would assure Medicare’s impending
bankruptcy. A Vanderbilt University analysis this year put an annual price of
about $26 billion on anti-obesity drugs for Medicare if just 10% of the system’s
enrollees were prescribed the medication.
Other research, however, shows it could also save the government billions, even
trillions over many years, because it would reduce some of the chronic
conditions and problems that stem from obesity.
An analysis this year from the University of Southern California’s Schaeffer
Center estimated the government could save as much as $245 billion in a decade,
with the majority of savings coming from reducing hospitalizations and other
care.
“What we did is we looked at the long-term health consequences of treating
obesity in the Medicare population,” said the study’s co-author, Darius
Lakdawalla, the director of research at the center. The Schaeffer Center
receives funding from pharmaceutical companies, including Eli Lilly.
Lakdawalla said it’s nearly impossible to put a cost on covering the drugs
because no one knows how many people will end up taking them or what the drugs
will be priced at.
The Congressional Budget Office, which is tasked with pricing out legislative
proposals, acknowledged this difficulty in an October blog post, with the
director calling for more research on the topic.
Overall, the agency “expects that the drug’s net cost to the Medicare program
would be significant over the next 10 years.”
The cost of the legislation is the biggest hang up in getting support, Ruiz
said.
“When we talk about the initial cost, I often have to educate the members that
the CBO does not take into account cost savings in their cost benefit analysis,”
Ruiz told the AP. “Taking that number in isolation, one does not get the full
picture of the full economies of reducing obesity and all of its comorbidities
in our patients.”
WHO WANTS MEDICARE TO COVER THE DRUGS?
Doctors say weight loss drugs are only a part of the most effective strategies
to treat a patient with obesity.
When Dr. Andrew Kraftson develops a plan with his patients at the University of
Michigan’s Weight Navigator program, it involves a “perfect marriage” of
behavioral intervention, health and diet education, and possibly anti-obesity
medication.
But with Medicare patients, he is limited in what he can prescribe.
“A blanket prohibition for use of anti-obesity medication is an antiquated way
of thinking and does not recognize obesity as a disease and is perpetuating
health disparities,” Kraftson said. “I’m not so ignorant to think that Medicare
should just start covering expensive treatments for everyone. But there is
something between all or nothing.”
Lawmakers have introduced some variation of legislation that would permit
Medicare coverage of weight loss drugs over the last decade. But this year’s
bill has garnered interest from more than 60 lawmakers, from self-proclaimed
budget hawk Rep. David Schweikert, R-Ariz., to progressive Rep. Judy Chu,
D-Calif.
Passage is a top priority for two lawmakers, Wenstrup and Sen. Tom Carper,
D-Del., before they retire next year.
Pharmaceutical companies also are readying for a lobbying blitz next year with
the drugs getting the OK from the FDA to be used for weight loss.
“Americans should have access to the medicines that their doctors believe they
should have,” Stephen Ubl, the president of the lobbying group, Pharmaceutical
Research and Manufacturers of America, said on a call with reporters last week.
“We would call on Medicare to cover these medicines.”
Already, Novo Nordisk has employed eight separate firms and spent nearly $20
million on lobbying the federal government on issues, including the Treat &
Reduce Obesity Act, since 2020, disclosures show. Eli Lilly has spent roughly
$2.4 million lobbying since 2021.
Advocates for groups such as the Obesity Society have been pushing for Medicare
coverage of the medications for years. But the momentum may be shifting, thanks
to the growing evidence that the obesity drugs can prevent strokes, heart
attacks, even death, said Ted Kyle, a policy advisor.
“The conversation has shifted from debating whether obesity treatment is
worthwhile to figuring out how to make the economics work,” he said. “This is
why I now believe the change is inevitable.”
___
Associated Press writers JoNel Aleccia in Temecula, California, and Brian
Slodysko contributed to this report.
by Taboola by Taboola
Suggested For You
Civil rights leader removed from movie theater for using his own chair
Undo
Homes.comAd Content
Advertisement View Thousands of New Home Listings For SaleHomes.com:
Advertisement Advertisement
Undo
Ex-Trump lawyer Michael Cohen says he unwittingly sent AI-generated fake legal
cases to his attorney
Undo
A tax increase, LGBTQ+ youth protections and more sick leave highlight
California’s new laws in 2024
Undo
Israeli-French hostage recounts harrowing experience in captivity
Undo
' ' '
' ' '
Skip Ad
Sorry, your browser does not support inline SVG.
Ad
Unmute
Arch Manning outlines his reasons for remaining a Texas Longhorn, even possibly
as a backupArch Manning says he envisions remaining at Texas even if current
starting quarterback Quinn Ewers returns next season.AP News
Undo
Kathy Griffin files for divorce ahead of her fourth wedding anniversaryComedian
Kathy Griffin has filed for divorce from longtime partner Randy Bick ahead of
the couple’s fourth wedding anniversary.AP News
Undo
Ad Content
Advertisement: GundryMD
U.S Cardiologist Discovers Why You Get Tired EasilyAdvertisement: GundryMD
Learn more
Undo
Advertisement: Life Tips Journal
1 Odd Trick Restores Your Eyes To Perfect 20/20 VisionAdvertisement: Life Tips
Journal
Learn more
Undo
Advertisement: GundryMD
MD: If You Have Dark Spots, Do This Immediately (It's Genius!)Advertisement:
GundryMD
Learn more
Undo
Ad Content
Advertisement: Beverly Hills MD
Is Your Neck Making You Look Old? Try This Easy Habit Before BedAdvertisement:
Beverly Hills MD
Learn more
Undo
Advertisement: WellnessGuide
Diabetes Is Not From Sweets! Meet The Number One EnemyAdvertisement:
WellnessGuide
Learn more
Undo
Advertisement: TheWalletGuru
29+ Coolest Gifts Nobody Would Think OfAdvertisement: TheWalletGuru
Learn more
Undo
Advertisement: WellnessGuide
When Neuropathy Hits, Try This (It's Genius!)Ivy League Discovery Helped
Americans Eliminate Neuropathy (WATCH)Advertisement: WellnessGuide
Learn more
Undo
Advertisement: Fitnus Sleeve
Bone On Bone? This ''bionic'' Knee Sleeve Will Transform Your Knees Back 17
YearsAdvertisement: Fitnus Sleeve
Learn more
Undo
Ad Content
Advertisement: New Mazda CX50
Mazda CX50 Is A True Head Turner (You'll Double Take At The Price)Advertisement:
New Mazda CX50
Undo
Advertisement: Smart Security Tips
Most Windows Users Didn’t Know They Can Block Ads (Do It Now)Advertisement:
Smart Security Tips
Learn More
Undo
Advertisement: Homes.com
Search Homes For Sale in New YorkAdvertisement: Homes.com
Learn More
Undo
Advertisement
by Taboolaby Taboola
Suggested For You
The Easy Blog by EasyBreathe.com
Need a new CPAP? Get one from home hassle freeThe Easy Blog by EasyBreathe.com
:Advertisement:Advertisement
Undo
GoFindYou
New York: These $250/Month Senior Living Apartments Are StunningGoFindYou
:Advertisement:Advertisement
Learn More
Undo
New Mazda CX-5
Killer New Mazda CX-5 Will Leave You Speechless (Take a Look at The Prices)New
Mazda CX-5
:Advertisement:Advertisement
Search Now
Undo
Badlands Ranch
This Viral Video Shows The Top 3 Dog Foods To Avoid At All CostBadlands Ranch
:Advertisement:Advertisement
Watch Now
Undo
The Associated Press is an independent global news organization dedicated to
factual reporting. Founded in 1846, AP today remains the most trusted source of
fast, accurate, unbiased news in all formats and the essential provider of the
technology and services vital to the news business. More than half the world’s
population sees AP journalism every day.
* The Associated Press
* ap.org
* Careers
* Advertise with us
* Contact Us
* Accessibility Statement
* Manage Your Choices
* Terms of Use
* Privacy Policy
* More From AP News
* About
* AP News Values and Principles
* AP’s Role in Elections
* AP Leads
* AP Definitive Source Blog
* AP Images Spotlight Blog
* AP Stylebook
Copyright 2023 The Associated Press. All Rights Reserved.
*
twitter
*
instagram
*
facebook
x
YOUR PRIVACY CHOICES: OPT OUT OF SALE OF PERSONAL INFORMATION AND
SHARING/PROCESSING OF PERSONAL INFORMATION FOR TARGETED ADS
To provide you with a more personalized and better-performing online experience,
our site uses tracking technologies, including cookies, to collect information
that may relate to you, your preferences, and your device. We may disclose this
information to third parties to support digital advertising and marketing
activities, as described in our Privacy Policy.
This use of information may be considered “selling” or “sharing/processing” for
targeted advertising under certain applicable laws. If you are a resident of a
US state with applicable laws, you may opt out of the sale of your personal info
or sharing/processing of your personal info for targeted advertising in the
“Manage Your Privacy Choices” section below.
If you decide not to allow the sale of personal information or
sharing/processing of personal information for targeted ads, you will continue
to see ads, but they may be less relevant or based only on information that we
collect directly from your use of the site. Your choices related to tracking
technologies are specific to the site/app on the browser/device where you are
making the selection, meaning that you must make Your Privacy Choices selections
on each site/app on each browser/device you use to access the site. You must
renew your selections for Your Privacy Choices each time you clear your cookies.
For additional information, please visit our Privacy Policy.
More informationDo Not Sell My Personal Information Form
Allow All
MANAGE CONSENT PREFERENCES
OPT OUT OF SALE OF PERSONAL INFORMATION AND SHARING/PROCESSING FOR TARGETED ADS
Opt Out of Sale of Personal Information and Sharing/Processing for Targeted Ads
FOR TRACKING TECHNOLOGIES - For California, Colorado, Connecticut, Utah, and
Virginia Residents Only: To opt out of the sale or sharing/processing of
personal information for targeted ads for this site/app on this browser/device,
switch the toggle above to OFF by moving it to the LEFT (it will turn gray) and
then clicking the “Confirm My Choices” button at the bottom.
FOR NAME AND EMAIL - For California, Colorado, Connecticut, Utah, and Virginia
Residents Only: To opt out of the use of your name, email, and other associated
personal information for targeted advertising activities, please complete and
submit a Do Not Sell or Share/Process My Personal Info Form (use the link
above).
* TARGETING COOKIES
Switch Label label
Targeting cookies may be set through our site by our advertising partners,
who may use the information they obtain to build a profile of your interests
and show you relevant ads on this and other sites. These cookies do not store
directly identifiable personal information, but they include information that
may uniquely identify your browser and internet device. If you decide to opt
out of targeted advertising, you will continue to see ads, but they may be
less relevant or based only on information that we collect directly from your
use of the site.
Back Button
COOKIE LIST
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Confirm My Choices
Menu
Menu
* World
* U.S.
* Politics
* Sports
* Entertainment
* Business
* Science
* Fact Check
* Oddities
* Health
* Video
* Climate
* Spotlight
* Photography
* Tech
* Lifestyle
* Religion
* Press Releases
* ...
* World
* Israel-Hamas War
* Russia-Ukraine War
* Latin America
* Europe
* Africa
* Middle East
* Asia Pacific
* U.S. News
* Australia
* China
* U.S.
* Politics
* Joe Biden
* Election 2024
* Congress
* Sports
* AP Top 25 College Football Poll
* NFL
* MLB
* NHL
* NBA
* WNBA
* Soccer
* Tennis
* Golf
* Entertainment
* Movie reviews
* Book reviews
* Celebrity
* Television
* Music
* Business
* Inflation
* Financial Markets
* Business Highlights
* Financial wellness
* Science
* Fact Check
* Oddities
* Health
* Video
* Climate
* Spotlight
* Photography
* Tech
* Artificial Intelligence
* Social Media
* Lifestyle
* Religion
* Press Releases
Search Query Submit Search
Show Search
* World
* Israel-Hamas War
* Russia-Ukraine War
* Latin America
* Europe
* Africa
* Middle East
* Asia Pacific
* U.S. News
* Australia
* China
* U.S.
* Politics
* Joe Biden
* Election 2024
* Congress
* Sports
* AP Top 25 College Football Poll
* NFL
* MLB
* NHL
* NBA
* WNBA
* Soccer
* Tennis
* Golf
* Entertainment
* Movie reviews
* Book reviews
* Celebrity
* Television
* Music
* Business
* Inflation
* Financial Markets
* Business Highlights
* Financial wellness
* Science
* Fact Check
* Oddities
* Health
* Video
* Climate
* Spotlight
* Photography
* Tech
* Artificial Intelligence
* Social Media
* Lifestyle
* Religion
* Press Releases
*
* The Associated Press is an independent global news organization dedicated to
factual reporting. Founded in 1846, AP today remains the most trusted source
of fast, accurate, unbiased news in all formats and the essential provider of
the technology and services vital to the news business. More than half the
world’s population sees AP journalism every day.
*
* *
twitter
*
instagram
*
facebook
*
* The Associated Press
* ap.org
* Careers
* Advertise with us
* Contact Us
* Accessibility Statement
* Manage Your Choices
* Terms of Use
* Privacy Policy
*
* More From AP News
* About
* AP News Values and Principles
* AP’s Role in Elections
* AP Leads
* AP Definitive Source Blog
* AP Images Spotlight Blog
* AP Stylebook
*
* Copyright 2023 The Associated Press. All Rights Reserved.
Keep on reading
Civil rights leader removed from movie theater for using his own chairA civil
rights leader was escorted by police out of a North Carolina movie theater after
he insisted on using his own chair for medical reasons.AP News
Group 3
Undo
Ex-Trump lawyer Michael Cohen says he unwittingly sent AI-generated fake legal
cases to his attorneyFormer Trump lawyer and fixer Michael Cohen says he
unwittingly passed along to his attorney bogus artificial intelligence-generated
legal case citations he got online before they were submitted to a judge in New
York.AP News
Group 3
Undo
A tax increase, LGBTQ+ youth protections and more sick leave highlight
California’s new laws in 2024A new year brings new laws in California. Most of
the new laws Democratic Gov. Gavin Newsom signed in 2023 take effect on Jan. 1,
2024.AP News
Group 3
Undo
Israeli-French hostage recounts harrowing experience in captivityAn Israeli
woman who recently returned from captivity in Gaza says she was groped by her
Palestinian kidnapper and lived in constant fear for weeks.AP News
Group 3
Undo
' ' '
' ' '
Arch Manning outlines his reasons for remaining a Texas Longhorn, even possibly
as a backupArch Manning says he envisions remaining at Texas even if current
starting quarterback Quinn Ewers returns next season.AP News
Undo
Advertisement: New Mazda CX50
Mazda CX50 Is A True Head Turner (You'll Double Take At The Price)Advertisement:
New Mazda CX50
Undo
Advertisement: Smart Security Tips
Most Windows Users Didn’t Know They Can Block Ads (Do It Now)Chrome users can
now block all ads and speed up their browsing; not only will you reduce your
data usage but also protect against malicious links. It's now easier than
ever!Advertisement: Smart Security Tips
Learn More
Undo
Kathy Griffin files for divorce ahead of her fourth wedding anniversaryComedian
Kathy Griffin has filed for divorce from longtime partner Randy Bick ahead of
the couple’s fourth wedding anniversary.AP News
Undo
Denmark’s Queen Margrethe II to step down from throne on Jan. 14The 83-year-old
monarch, whose role is largely ceremonial, made the announcement on Sunday
during her New Year’s speech.AP News
Undo
British actor Tom Wilkinson, known for ‘The Full Monty’ and ‘Michael Clayton,’
dies at 75Tom Wilkinson, the Oscar-nominated British actor known for his roles
in “The Full Monty,” “Michael Clayton” and “The Best Exotic Marigold Hotel,” has
died at age 75, according to his family.AP News
Undo
Cargo ship carrying burning lithium-ion batteries reaches Alaska, but kept
offshore for safetyU.S. Coast Guard said a large cargo ship with an active fire
in its hold is being kept offshore of an Alaska port as a precaution while
efforts are undertaken to extinguish the flames.AP News
Undo
Perspective: Children born poor have little margin for mistakes or bad
decisions, regardless of raceAlfred King was lying in the parking lot of a small
apartment building, mortally wounded when police in Alexandria, Louisiana, got
to the intersection of 12th and Magnolia streets shortly before 1:30 a.m., Jan.
20.AP News
Undo
GundryMD
MD: If You Have Dark Spots, Do This Immediately (It's Genius!)GundryMD
:Advertisement:Advertisement
Learn more
Undo
Homes.com
View Thousands of New Home Listings For SaleHomes.com
:Advertisement:Advertisement
Learn More
Undo
On New Year’s Eve, DeSantis urges crowd to defy odds and help him ‘win the Iowa
caucuses’Ron DeSantis is underscoring how much Iowa means to him, campaigning
there into the waning hours of 2023.AP News
Undo
In rare apology, Israeli minister says she ‘sinned’ for her role in reforms that
tore country apartGalit Distel Atbaryan, former member of Prime Minister
Netanyahu’s political party, offered public apologies for the internal strife
that preceded Hamas’ Oct. 7 attack.AP News
Undo
WHY ARE YOU REPORTING THIS AD?
Please make a selection.
Plays sound Contains adult content Covers the page Other
ADDITIONAL INFORMATION
Please help us by describing the ad.
Only 500 characters are allowed.
Report ad
Thank you for letting us know.
Powered by
×
Enter your email to sign up for the Morning Wire newsletter
close email sign up dialog
Never miss what matters
Start your day with
The Morning Wire
Get the facts you need — now with a new look.
Please enter above
By checking this box, you agree to AP's Terms of Use and acknowledge that AP may
collect and use your data pursuant to our Privacy Policy.
Please enter above
Join now
Decline
You're subscribed!
Interested in more?
Photo Gallery, See the news through AP’s lens. Our most compelling photos -
delivered Sundays.
Please enter above
Join now
No thanks
close email sign up dialog